Investigation and pending class action lawsuit against Solvay Pharmaceuticals claiming that the drug maker has engaged in false and illegal marketing of Estratest, a hormone replacement therapy drug the company has been marketing without FDA approval.
The class action lawsuit alleges Solvay Pharmaceuticals marketing materials falsely stated that the hormone replacement therapy drug Estratest worked to treat hot flashes, something the FDA recently began questioning, and implied the drug was approved by the FDA. Although Solvay applied for approval in 1981, the FDA never approved Estratest for its marketed use.
Do not change medications without first consulting your doctor.
Name (Stock Symbol)
Solvay Pharmaceuticals, Inc. and its wholly owned subsidiary Unimed Pharmaceuticals, Inc., are part of Solvay S.A., a Belgium-based chemical and pharmaceutical company.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.